Immunogen | IMGN - Ebitda



Ebitda Veränderung Datum
AbbVie USD 3.69B 1.68B 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Amgen USD 3.86B 1.28B 2026-03
Astellas Pharma JPY 235.24B 136.32B 2026-06
AstraZeneca USD 5.16B 510M 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Exelixis USD 255.4M 2.89M 2026-06
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -30.2M 52.15M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 5.41B 431M 2026-03
Pfizer USD 6.01B 18M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 2.72B 2.94B 2026-03